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Perianal Pigmented Variant of Dermatofibrosarcoma Protuberans: 
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• Dermatofibrosarcoma protuberans (DFSP) is a soft tissue sarcoma that 
accounts for 0.1% of cancers
• Incidence of 4.1 cases per million person-years in the US
• Incidence greater than 5.0 cases per million person-years in 
Detroit1
• Most commonly occurs on the trunk and extremities 
• Less than 1% occur in the genital region1
• Only 3 perianal DFSP cases reported in the literature2-4
• Histopathology characteristics include storiform spindle cells with minimal 
atypia, CD34 positive, factor XIIIa and S100 negative, and can be 
associated with the presence of COL1A1-PDGFRβ fusion gene5
• Bednar or pigmented type occurs in less than 5% of DFSP and is more 
common in African Americans1,5
• Locally aggressive with historically high local recurrence rates up to 
50%6,9
• Current NCCN guidelines recommend 2 to 4 cm margins to the investing 
fascia6
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• 44-year-old African American female presented with mildly pruritic, 
non-tender, non-draining left buttock lesion first noted 2 years before
• Firm 1 cm hyperpigmented scar-like papule thought to be from 
prior furunculosis or epidermoid cyst
• Elected for continued observation
• 1 year later, lesion reevaluated and found to have with increasing 
hyperpigmentation and size; patient referred for surgical evaluation
• Single 2x2 cm indurated, non-tender, hyperpigmented perianal 
nodule at the 10 o’clock position was identified
• Initial excisional biopsy unexpectedly diagnosed Bednar DFSP 
with histology of storiform spindle cells, CD34 positive, S100 
negative, and dendritic melanin-containing cells
• Subsequently, patient underwent definitive wide local excision with 
primary closure
• However, circumferential margins were limited to 1 cm due to proximity to 
anal verge
• Follow-up MRI at one-year post-excision without evidence of recurrence
• Currently undergoing annual skin exams with primary care physician for 
surveillance
• This is the first perianal Bednar DFSP case reported and one of few 
perianal DFSP cases found in the literature
• This case highlights the indolent course of DFSP delaying diagnosis as 
well as difficulties achieving recommended surgical margins while 
preserving continence
• DFSP is malignant fibroblastic tumor traditionally associated with high 
rates of local recurrence and rarely metastases
• Its indolent growth pattern can be associated with initial misdiagnosis or 
delayed diagnosis and treatment, as was the case here
• Treatment is surgical excision with meticulous histologic examination of 
the specimen to ensure adequate margins
• DFSP infiltrates subcutaneous tissues through finger-like 
extensions complicating analysis of margins
• Proximity to the anal verge limited attainable margins to 1 cm 
while avoiding incontinence
• Mohs micrographic surgery has been utilized to obtain negative margins 
with similar recurrence rates as compared to wide local excision with 
careful microscopic examination
• Recent data suggests recurrence rates as low as 1% in both 
approaches9,10
• Reconstruction or tissue undermining should be avoided until negative 
histologic margins are confirmed
• Imatinib, a protein tyrosine kinase inhibitor, can be used for recurrent or 
unresectable DFSP with t(17;22) translocation6
• Radiation therapy has been utilized with 86-93% 10 year disease free 
survival and could be employed if complete resection is not feasible7,8
Figure 5. While nonspecific and seen 
in spindle cell tumors, CD34 
immunohistochemical stain strongly 
and diffusely positive consistent with 
DFSP
Figure 3. Hematoxylin and eosin, 
storiform pattern of neoplastic cells 
Figure 2. Hematoxylin and eosin, 
characteristic “honeycomb” pattern 
Figure 4. Hematoxylin and eosin, 
uniform spindle cells without atypia
Figure 6. Fontana-positive melanin 
pigment in dendritic cells consistent 
with Bednar variant that occurs in 
<5% of DFSP 
Figure 7. 1 year post-operative, well 
healed incision with proximity to anal 
verge evident
Figure 1. Indurated 
hyperpigmented nodule on initial 
surgical evaluation after 3 years of 
symptoms
